Open access · CC-BY
via OpenAlex
Protein-Protein Interactions in Alpha-Synuclein Biogenesis: New Potential Targets in Parkinson’s Disease
Sarah M. Hernandez, Elena B. Tikhonova, Andrey L. Karamyshev
Frontiers in Aging Neuroscience · 2020 · ▲ 43 citations
Abstract
Parkinson's disease (PD) is a debilitating neurodegenerative disorder defined by a loss of dopamine-producing neurons in the substantia nigra in the brain. It is associated with cytosolic inclusions known as Lewy bodies. The major component of Lewy bodies is aggregated alpha-synuclein. The molecular mechanism of alpha-synuclein aggregation is not known. Our conceptual model is that alpha-synuclein aggregates due to a dysregulation of its interactions with other protein partners that are required for its biogenesis. In this mini review article, we identified alpha-synuclein interactions using both current literature and predictive pathway analysis. Alterations of these interactions may be crucial elements for the molecular mechanism of the protein aggregation and related pathology in the disease. Identification of alpha-synuclein interactions provides valuable tools to understand PD pathology and find new pharmacological targets for disease treatment.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fnagi.2020.00072
- Canonical
- link ↗
- Fetched
- 2026-10-27 MST
Cite this
APA
Hernandez, S.M., Tikhonova, E.B., & Karamyshev, A.L. (2020). Protein-Protein Interactions in Alpha-Synuclein Biogenesis: New Potential Targets in Parkinson’s Disease. <em>Frontiers in Aging Neuroscience</em>. https://doi.org/10.3389/fnagi.2020.00072
Vancouver
Hernandez SM, Tikhonova EB, Karamyshev AL. Protein-Protein Interactions in Alpha-Synuclein Biogenesis: New Potential Targets in Parkinson’s Disease. Frontiers in Aging Neuroscience. 2020. doi:10.3389/fnagi.2020.00072.
BibTeX
@article{sarah2020Protei,
title = {Protein-Protein Interactions in Alpha-Synuclein Biogenesis: New Potential Targets in Parkinson’s Disease},
author = {Sarah M. Hernandez and Elena B. Tikhonova and Andrey L. Karamyshev},
journal = {Frontiers in Aging Neuroscience},
year = {2020},
doi = {10.3389/fnagi.2020.00072},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Acta Medica 2021
Open access · CC-BY
An Overview of Alpha Synuclein Protein and Its Role in Parkinson’s disease
Human Molecular Genetics 2010
Open access · OA
TRAF6 promotes atypical ubiquitination of mutant DJ-1 and alpha-synuclein and is localized to Lewy bodies in sporadic Parkinson's disease brains
Molecular Neurodegeneration 2023
Open access · CC-BY
Peptide-based approaches to directly target alpha-synuclein in Parkinson’s disease
Frontiers in Cell and Developmental Biology 2021
Open access · CC-BY
PARK Genes Link Mitochondrial Dysfunction and Alpha-Synuclein Pathology in Sporadic Parkinson’s Disease
Oxford University Research Archive (ORA) (University of Oxford) 2015
Preprint · OA
The role of alpha-synuclein oligomers in Parkinson's disease pathophysiology and biology
Journal of Neurochemistry 2025
Open access · CC-BY